[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"antibody-mediated\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:antibody-mediated":19},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":4,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":4,"minAge":4,"maxAge":4,"enrollmentInfo":4,"targetDuration":4,"studyType":15,"phases":4,"briefSummary":16,"conditions":17,"keywords":4,"overallStatus":20,"whyStopped":4,"lastUpdateSubmitDate":21,"lastUpdatePostDateStruct":22,"startDateStruct":4,"completionDateStruct":4,"leadSponsor":25,"locationsCount":4},"100652861","compassionate-use-of-vonsetamig-100652861",false,"NCT07780110","Compassionate Use of Vonsetamig","Eligibility will be determined during the application review process.","EXPANDED_ACCESS","Provide Compassionate Use of Vonsetamig",[18,19],"Plasma Cell Mediated","Antibody Mediated","AVAILABLE","2026-08-18",{"date":23,"type":24},"2026-08-21","ACTUAL",{"name":26,"class":27},"Regeneron Pharmaceuticals","INDUSTRY"]